KEGG   PATHWAY: fca05200
Entry
fca05200                    Pathway                                
Name
Pathways in cancer - Felis catus (domestic cat)
Class
Human Diseases; Cancer: overview
Pathway map
fca05200  Pathways in cancer
fca05200

Organism
Felis catus (domestic cat) [GN:fca]
Gene
101098832  DCC; netrin receptor DCC isoform X1 [KO:K06765]
493932  CASP3; caspase-3 [KO:K02187] [EC:3.4.22.56]
768260  CASP9; caspase-9 isoform X1 [KO:K04399] [EC:3.4.22.62]
101096960  APPL1; DCC-interacting protein 13-alpha isoform X1 [KO:K08733]
101095391  CDH1; cadherin-1 [KO:K05689]
101097342  CTNNB1; catenin beta-1 [KO:K02105]
101089324  CTNNA1; catenin alpha-1 [KO:K05691]
101088568  CTNNA2; catenin alpha-2 isoform X1 [KO:K05691]
101086346  CTNNA3; catenin alpha-3 isoform X1 [KO:K05691]
101088804  AXIN1; LOW QUALITY PROTEIN: axin-1 [KO:K02157]
101093061  AXIN2; axin-2 isoform X1 [KO:K04385]
101096138  APC; adenomatous polyposis coli protein isoform X4 [KO:K02085]
101097211  APC2; adenomatous polyposis coli protein 2 isoform X1 [KO:K02085]
101081660  GSK3B; glycogen synthase kinase-3 beta isoform X2 [KO:K03083] [EC:2.7.11.26]
101098768  TCF7; LOW QUALITY PROTEIN: transcription factor 7 [KO:K02620]
101089850  TCF7L1; transcription factor 7-like 1 isoform X3 [KO:K04490]
101095618  TCF7L2; transcription factor 7-like 2 isoform X1 [KO:K04491]
101088077  LEF1; lymphoid enhancer-binding factor 1 isoform X3 [KO:K04492]
493835  BIRC5; baculoviral IAP repeat-containing protein 5 [KO:K08731]
100379628  MYC; myc proto-oncogene protein [KO:K04377]
100037407  CCND1; G1/S-specific cyclin-D1 [KO:K04503]
101094190  WNT1; proto-oncogene Wnt-1 [KO:K03209]
493672  WNT2; protein Wnt-2 precursor [KO:K00182]
101080904  WNT2B; protein Wnt-2b [KO:K00182]
101088533  WNT3; proto-oncogene Wnt-3 [KO:K00312]
101080607  WNT3A; protein Wnt-3a [KO:K00312]
101095185  WNT4; protein Wnt-4 isoform X1 [KO:K00408]
101085809  WNT5B; protein Wnt-5b [KO:K00444]
101080694  WNT5A; protein Wnt-5a isoform X1 [KO:K00444]
101099392  WNT6; protein Wnt-6 [KO:K00445]
101083664  WNT7A; protein Wnt-7a isoform X1 [KO:K00572]
101095592  WNT7B; protein Wnt-7b isoform X1 [KO:K00572]
101089489  WNT8A; LOW QUALITY PROTEIN: protein Wnt-8a [KO:K00714]
101096357  WNT8B; protein Wnt-8b [KO:K00714]
101080844  WNT9B; protein Wnt-9b [KO:K01064]
111560436  WNT9A; protein Wnt-9a isoform X1 [KO:K01064]
101092455  WNT10A; protein Wnt-10a [KO:K01357]
101093948  WNT10B; protein Wnt-10b [KO:K01357]
101100080  WNT11; protein Wnt-11 [KO:K01384]
101090252  WNT16; protein Wnt-16 [KO:K01558]
101082735  FZD1; frizzled-1 [KO:K02432]
101087255  FZD7; frizzled-7 [KO:K02432]
101085253  FZD2; frizzled-2 [KO:K02235]
101095250  FZD3; frizzled-3 isoform X1 [KO:K02329]
101093710  FZD4; frizzled-4 isoform X1 [KO:K02354]
101101229  FZD8; frizzled-8 [KO:K02375]
101097508  FZD5; frizzled-5 [KO:K02375]
101101443  FZD6; frizzled-6 [KO:K02376]
101087697  FZD9; frizzled-9 [KO:K02842]
101081169  FZD10; frizzled-10 [KO:K02842]
101084481  LRP5; low-density lipoprotein receptor-related protein 5 [KO:K03068]
101082246  LRP6; low-density lipoprotein receptor-related protein 6 isoform X2 [KO:K03068]
101094385  DVL2; segment polarity protein dishevelled homolog DVL-2 isoform X1 [KO:K02353]
101084782  DVL1; segment polarity protein dishevelled homolog DVL-1 isoform X1 [KO:K02353]
101095675  DVL3; segment polarity protein dishevelled homolog DVL-3 isoform X2 [KO:K02353]
101087686  FRAT1; proto-oncogene FRAT1 [KO:K03069]
105261037  FRAT2; GSK-3-binding protein FRAT2 [KO:K03096]
101090463  F2; prothrombin [KO:K01313] [EC:3.4.21.5]
101093714  AGT; angiotensinogen [KO:K09821]
101100861  F2R; LOW QUALITY PROTEIN: proteinase-activated receptor 1 [KO:K03914]
101081027  F2RL3; proteinase-activated receptor 4 isoform X1 [KO:K04236]
101092556  LPAR1; lysophosphatidic acid receptor 1 [KO:K04289]
101100950  LPAR2; lysophosphatidic acid receptor 2 [KO:K04291]
101097996  LPAR3; lysophosphatidic acid receptor 3 [KO:K04294]
101087973  LPAR4; lysophosphatidic acid receptor 4 [KO:K04275]
102899848  LPAR5; lysophosphatidic acid receptor 5 [KO:K08390]
101095629  LPAR6; lysophosphatidic acid receptor 6 [KO:K04273]
101082936  AGTR1; type-1 angiotensin II receptor [KO:K04166]
101093316  GNA12; guanine nucleotide-binding protein subunit alpha-12 isoform X1 [KO:K04346]
101087625  GNA13; guanine nucleotide-binding protein subunit alpha-13 [KO:K04639]
101085657  ARHGEF12; rho guanine nucleotide exchange factor 12 isoform X1 [KO:K07532]
101080861  ARHGEF11; rho guanine nucleotide exchange factor 11 isoform X1 [KO:K12331]
101083892  ARHGEF1; LOW QUALITY PROTEIN: rho guanine nucleotide exchange factor 1 [KO:K12330]
101094361  PLEKHG5; pleckstrin homology domain-containing family G member 5 isoform X1 [KO:K19464]
101084011  RHOA; transforming protein RhoA [KO:K04513]
101092552  ROCK1; rho-associated protein kinase 1 isoform X1 [KO:K04514] [EC:2.7.11.1]
101094501  ROCK2; rho-associated protein kinase 2 isoform X1 [KO:K17388] [EC:2.7.11.1]
493806  CXCL12; stromal cell-derived factor 1 precursor [KO:K10031]
493676  CXCR4; C-X-C chemokine receptor type 4 [KO:K04189]
101092837  GNAI1; guanine nucleotide-binding protein G(i) subunit alpha-1 [KO:K04630]
101100320  GNAI3; guanine nucleotide-binding protein G(i) subunit alpha-3 [KO:K04630]
101089679  GNAI2; guanine nucleotide-binding protein G(i) subunit alpha-2 [KO:K04630]
101097794  PTGER1; prostaglandin E2 receptor EP1 subtype isoform X1 [KO:K04258]
100169967  PTGER2; prostaglandin E2 receptor EP2 subtype [KO:K04259]
101083952  PTGER3; prostaglandin E2 receptor EP3 subtype isoform X1 [KO:K04260]
100169968  PTGER4; prostaglandin E2 receptor EP4 subtype [KO:K04261]
101098453  guanine nucleotide-binding protein G(s) subunit alpha isoforms XLas isoform X2 [KO:K04632]
102900772  neuroendocrine secretory protein 55 [KO:K04632]
101101375  ADCY1; adenylate cyclase type 1 [KO:K08041] [EC:4.6.1.1]
101094327  ADCY2; adenylate cyclase type 2 isoform X1 [KO:K08042] [EC:4.6.1.1]
101088157  ADCY3; adenylate cyclase type 3 isoform X1 [KO:K08043] [EC:4.6.1.1]
101097735  ADCY4; adenylate cyclase type 4 isoform X1 [KO:K08044] [EC:4.6.1.1]
101100749  ADCY5; adenylate cyclase type 5 isoform X1 [KO:K08045] [EC:4.6.1.1]
101091211  ADCY6; adenylate cyclase type 6 isoform X2 [KO:K08046] [EC:4.6.1.1]
101094148  ADCY7; adenylate cyclase type 7 isoform X2 [KO:K08047] [EC:4.6.1.1]
101087555  ADCY8; adenylate cyclase type 8 isoform X1 [KO:K08048] [EC:4.6.1.1]
101095942  ADCY9; adenylate cyclase type 9 [KO:K08049] [EC:4.6.1.1]
101090494  PRKACA; cAMP-dependent protein kinase catalytic subunit alpha isoform X3 [KO:K04345] [EC:2.7.11.11]
101095353  PRKACB; cAMP-dependent protein kinase catalytic subunit beta isoform X1 [KO:K04345] [EC:2.7.11.11]
101086580  GNB1; guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 [KO:K04536]
101093317  GNB2; guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-2 [KO:K04537]
101084799  GNB3; guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-3 [KO:K07825]
101091855  GNB4; guanine nucleotide-binding protein subunit beta-4 [KO:K04538]
101081809  GNB5; guanine nucleotide-binding protein subunit beta-5 isoform X1 [KO:K04539]
101097491  GNG2; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-2 [KO:K07826]
101091560  GNG3; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-3 [KO:K04540]
101081928  GNG4; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-4 isoform X1 [KO:K04541]
111561761  GNG5; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-5 [KO:K04542]
101088219  GNG7; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-7 [KO:K04543]
101090817  GNG8; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-8 isoform X2 [KO:K04544]
111557526  GNG10; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-10 [KO:K04545]
101088915  GNG11; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-11 [KO:K04546]
101084346  GNG14; putative guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-14 [KO:K04347]
101089378  GNG12; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-12 [KO:K04347]
101086526  GNG13; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-13 [KO:K04547]
101088476  GNGT1; guanine nucleotide-binding protein G(T) subunit gamma-T1 [KO:K04548]
101096184  GNGT2; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-T2 [KO:K04549]
101089498  COL4A6; collagen alpha-6(IV) chain isoform X1 [KO:K06237]
101093002  COL4A5; collagen alpha-5(IV) chain isoform X4 [KO:K06237]
101096282  COL4A2; collagen alpha-2(IV) chain [KO:K06237]
101096030  COL4A1; collagen alpha-1(IV) chain isoform X2 [KO:K06237]
101087512  COL4A3; collagen alpha-3(IV) chain isoform X1 [KO:K06237]
101091469  COL4A4; collagen alpha-4(IV) chain isoform X1 [KO:K06237]
101083299  LAMA1; laminin subunit alpha-1 isoform X3 [KO:K05637]
101092612  LAMA2; laminin subunit alpha-2 isoform X7 [KO:K05637]
101100161  LAMA3; laminin subunit alpha-3 isoform X1 [KO:K06240]
101083923  LAMA5; laminin subunit alpha-5 isoform X1 [KO:K06240]
101086907  LAMA4; laminin subunit alpha-4 isoform X2 [KO:K06241]
101080367  LAMB1; laminin subunit beta-1 [KO:K05636]
101082047  LAMB2; laminin subunit beta-2 isoform X1 [KO:K06243]
101088641  LAMB3; laminin subunit beta-3 [KO:K06244]
101101552  LAMB4; laminin subunit beta-4 isoform X1 [KO:K06245]
101090321  LAMC1; laminin subunit gamma-1 [KO:K05635]
101089571  LAMC2; laminin subunit gamma-2 [KO:K06246]
101098499  LAMC3; laminin subunit gamma-3 [KO:K06247]
101081746  FN1; fibronectin isoform X1 [KO:K05717]
101090237  ITGA2; integrin alpha-2 [KO:K06481]
101100930  ITGA2B; integrin alpha-IIb [KO:K06476]
101093156  ITGA3; integrin alpha-3 isoform X1 [KO:K06482]
101092454  ITGA6; integrin alpha-6 isoform X1 [KO:K06485]
101085820  ITGAV; integrin alpha-V [KO:K06487]
751821  ITGB1; integrin beta-1 precursor [KO:K05719]
101095952  PTK2; focal adhesion kinase 1 isoform X1 [KO:K05725] [EC:2.7.10.2]
101094274  PIK3CD; LOW QUALITY PROTEIN: phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform [KO:K00922] [EC:2.7.1.153]
101091892  PIK3CB; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform [KO:K00922] [EC:2.7.1.153]
101097413  PIK3CA; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform [KO:K00922] [EC:2.7.1.153]
100271864  PIK3R1; phosphatidylinositol 3-kinase regulatory subunit alpha isoform X3 [KO:K02649]
101093286  phosphatidylinositol 3-kinase regulatory subunit gamma isoform X2 [KO:K02649]
101093586  PIK3R2; phosphatidylinositol 3-kinase regulatory subunit beta [KO:K02649]
101091813  PTEN; phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN isoform X1 [KO:K01110] [EC:3.1.3.16 3.1.3.48 3.1.3.67]
105260486  NKX3-1; homeobox protein Nkx-3.1 [KO:K09348]
101087931  AKT1; RAC-alpha serine/threonine-protein kinase [KO:K04456] [EC:2.7.11.1]
101092818  AKT3; RAC-gamma serine/threonine-protein kinase isoform X4 [KO:K04456] [EC:2.7.11.1]
100499544  AKT2; RAC-beta serine/threonine-protein kinase isoform X4 [KO:K04456] [EC:2.7.11.1]
101095617  CHUK; inhibitor of nuclear factor kappa-B kinase subunit alpha isoform X1 [KO:K04467] [EC:2.7.11.10]
100142682  IKBKB; inhibitor of nuclear factor kappa-B kinase subunit beta isoform X2 [KO:K07209] [EC:2.7.11.10]
101086544  IKBKG; NF-kappa-B essential modulator isoform X1 [KO:K07210]
101090622  NFKBIA; NF-kappa-B inhibitor alpha [KO:K04734]
100142683  NFKB1; nuclear factor NF-kappa-B p105 subunit isoform X1 [KO:K02580]
101080578  NFKB2; nuclear factor NF-kappa-B p100 subunit [KO:K04469]
101096604  RELA; transcription factor p65 [KO:K04735]
100126581  PTGS2; prostaglandin G/H synthase 2 precursor [KO:K11987] [EC:1.14.99.1]
101087020  NOS2; nitric oxide synthase, inducible isoform X2 [KO:K13241] [EC:1.14.13.39]
493934  BCL2; apoptosis regulator Bcl-2 [KO:K02161]
101083444  baculoviral IAP repeat-containing protein 3 [KO:K16060]
101101663  BIRC2; baculoviral IAP repeat-containing protein 2 [KO:K16060]
101090594  E3 ubiquitin-protein ligase XIAP [KO:K04725] [EC:2.3.2.27]
101080371  BIRC7; baculoviral IAP repeat-containing protein 7 isoform X1 [KO:K16061]
493701  BCL2L1; bcl-2-like protein 1 [KO:K04570]
101087620  TRAF1; TNF receptor-associated factor 1 isoform X1 [KO:K03172]
101096363  TRAF2; TNF receptor-associated factor 2 isoform X1 [KO:K03173] [EC:2.3.2.27]
101096739  TRAF3; TNF receptor-associated factor 3 isoform X1 [KO:K03174]
101096365  TRAF4; TNF receptor-associated factor 4 [KO:K09848]
101086032  TRAF5; TNF receptor-associated factor 5 isoform X1 [KO:K09849]
101099750  TRAF6; TNF receptor-associated factor 6 [KO:K03175] [EC:2.3.2.27]
101098152  MTOR; serine/threonine-protein kinase mTOR isoform X3 [KO:K07203] [EC:2.7.11.1]
101091812  RPS6KB2; ribosomal protein S6 kinase beta-2 isoform X3 [KO:K04688] [EC:2.7.11.1]
101092561  RPS6KB1; ribosomal protein S6 kinase beta-1 isoform X2 [KO:K04688] [EC:2.7.11.1]
768269  BAD; bcl2-associated agonist of cell death [KO:K02158]
101096628  FOXO1; forkhead box protein O1 [KO:K07201]
493939  MDM2; E3 ubiquitin-protein ligase Mdm2 [KO:K06643] [EC:2.3.2.27]
493847  TP53; cellular tumor antigen p53 [KO:K04451]
493958  CDKN1B; cyclin-dependent kinase inhibitor 1B [KO:K06624]
493943  CDKN1A; cyclin-dependent kinase inhibitor 1 [KO:K06625]
101101671  BCR; breakpoint cluster region protein isoform X1 [KO:K08878] [EC:2.7.11.1]
101087622  ABL1; tyrosine-protein kinase ABL1 isoform X1 [KO:K06619] [EC:2.7.10.2]
101084908  CRKL; crk-like protein isoform X1 [KO:K04438]
101086100  CRK; adapter molecule crk isoform X1 [KO:K04438]
101096508  CBL; E3 ubiquitin-protein ligase CBL isoform X1 [KO:K04707] [EC:2.3.2.27]
101090913  STAT5A; signal transducer and activator of transcription 5A isoform X1 [KO:K11223]
101090663  STAT5B; signal transducer and activator of transcription 5B isoform X1 [KO:K11224]
493888  PIM1; serine/threonine-protein kinase pim-1 [KO:K04702] [EC:2.7.11.1]
101098037  PIM2; serine/threonine-protein kinase pim-2 [KO:K08806] [EC:2.7.11.1]
101099143  KNG1; kininogen-1 isoform X1 [KO:K03898]
494214  EDN1; endothelin-1 precursor [KO:K16366]
101082667  B2 bradykinin receptor isoform X1 [KO:K03916]
101083419  EDNRA; endothelin-1 receptor [KO:K04197]
101086531  EDNRB; endothelin receptor type B [KO:K04198]
101094708  GNAQ; guanine nucleotide-binding protein G(q) subunit alpha isoform X2 [KO:K04634]
101086541  GNA11; guanine nucleotide-binding protein subunit alpha-11 [KO:K04635]
101090942  PLCB2; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2 isoform X1 [KO:K05858] [EC:3.1.4.11]
101092961  PLCB3; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-3 isoform X1 [KO:K05858] [EC:3.1.4.11]
101092262  PLCB1; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1 isoform X1 [KO:K05858] [EC:3.1.4.11]
101090005  PLCB4; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-4 isoform X1 [KO:K05858] [EC:3.1.4.11]
101086433  PRKCA; protein kinase C alpha type isoform X1 [KO:K02677] [EC:2.7.11.13]
101088970  PRKCB; protein kinase C beta type isoform X3 [KO:K19662] [EC:2.7.11.13]
101082196  PRKCG; protein kinase C gamma type isoform X1 [KO:K19663] [EC:2.7.11.13]
751114  IL2; interleukin-2 precursor [KO:K05429]
111560806  interleukin-3-like [KO:K04736]
751514  IL4; interleukin-4 precursor [KO:K05430]
493803  IL5; interleukin-5 precursor [KO:K05428]
493687  IL6; interleukin-6 precursor [KO:K05405]
101084597  IL7; interleukin-7 isoform X1 [KO:K05431]
493741  IL12A; interleukin-12 subunit alpha precursor [KO:K05406]
768273  IL12B; interleukin-12 subunit beta precursor [KO:K05425]
101084678  IL13; interleukin-13 isoform X2 [KO:K05435]
493682  IL15; interleukin-15 precursor [KO:K05433]
654423  IL23A; interleukin-23 subunit alpha isoform X3 [KO:K05426]
493801  EPO; erythropoietin precursor [KO:K05437]
493648  IFNA8; interferon alpha-8 precursor [KO:K05414]
493653  IFNA7; interferon alpha precursor [KO:K05414]
101088440  interferon alpha-2-like [KO:K05414]
101081371  interferon alpha-like [KO:K05414]
493840  IFNA5; interferon alpha-5 [KO:K05414]
111557596  interferon alpha-like [KO:K05414]
493965  IFNG; interferon gamma precursor [KO:K04687]
493953  IL2RA; interleukin-2 receptor subunit alpha precursor [KO:K05068]
101092622  IL2RB; interleukin-2 receptor subunit beta isoform X1 [KO:K05069]
101090239  IL2RG; cytokine receptor common subunit gamma [KO:K05070]
105261394  IL3RA; interleukin-3 receptor subunit alpha isoform X1 [KO:K04737]
101096277  IL4R; interleukin-4 receptor subunit alpha [KO:K05071]
101091636  CSF2RB; cytokine receptor common subunit beta [KO:K04738]
101099031  IL5RA; interleukin-5 receptor subunit alpha [KO:K05067]
101085689  IL6R; interleukin-6 receptor subunit alpha [KO:K05055]
101089832  IL6ST; interleukin-6 receptor subunit beta isoform X1 [KO:K05060]
101100697  IL7R; interleukin-7 receptor subunit alpha [KO:K05072]
101093085  IL12RB1; interleukin-12 receptor subunit beta-1 isoform X1 [KO:K05063]
101088012  IL12RB2; interleukin-12 receptor subunit beta-2 isoform X1 [KO:K05064]
101091351  IL13RA1; interleukin-13 receptor subunit alpha-1 [KO:K05076]
101082243  IL15RA; interleukin-15 receptor subunit alpha isoform X1 [KO:K05074]
101087763  IL23R; interleukin-23 receptor [KO:K05065]
101081364  EPOR; erythropoietin receptor isoform X2 [KO:K05079]
101092535  IFNAR1; interferon alpha/beta receptor 1 isoform X1 [KO:K05130]
101090285  IFNAR2; interferon alpha/beta receptor 2 [KO:K05131]
101086811  IFNGR1; interferon gamma receptor 1 [KO:K05132]
101092286  IFNGR2; interferon gamma receptor 2 [KO:K05133]
101094586  EML4; echinoderm microtubule-associated protein-like 4 isoform X1 [KO:K15420]
101091689  ALK; ALK tyrosine kinase receptor isoform X1 [KO:K05119] [EC:2.7.10.1]
101093110  RASGRP1; RAS guanyl-releasing protein 1 isoform X4 [KO:K04350]
101094450  RASGRP2; RAS guanyl-releasing protein 2 isoform X1 [KO:K12361]
101085456  RASGRP3; ras guanyl-releasing protein 3 isoform X1 [KO:K12362]
101094467  RASGRP4; RAS guanyl-releasing protein 4 isoform X4 [KO:K12363]
101084377  JAK1; tyrosine-protein kinase JAK1 [KO:K11217] [EC:2.7.10.2]
101088959  JAK2; tyrosine-protein kinase JAK2 isoform X3 [KO:K04447] [EC:2.7.10.2]
101092339  JAK3; tyrosine-protein kinase JAK3 [KO:K11218] [EC:2.7.10.2]
101095698  STAT3; signal transducer and activator of transcription 3 isoform X1 [KO:K04692]
101084561  STAT1; signal transducer and activator of transcription 1-alpha/beta [KO:K11220]
101099224  STAT2; signal transducer and activator of transcription 2 isoform X1 [KO:K11221]
101080650  STAT4; signal transducer and activator of transcription 4 isoform X1 [KO:K11222]
101089873  STAT6; signal transducer and activator of transcription 6 [KO:K11225]
493845  VEGFA; vascular endothelial growth factor A precursor [KO:K05448]
101092465  VEGFB; vascular endothelial growth factor B isoform X1 [KO:K16858]
101095904  PGF; placenta growth factor isoform X8 [KO:K16859]
493703  VEGFD; vascular endothelial growth factor D [KO:K05449]
101085368  VEGFC; vascular endothelial growth factor C [KO:K05449]
101094921  TGFA; protransforming growth factor alpha isoform X1 [KO:K08774]
493978  EGF; pro-epidermal growth factor precursor [KO:K04357]
100510799  EGFR; epidermal growth factor receptor isoform X1 [KO:K04361] [EC:2.7.10.1]
751824  ERBB2; receptor tyrosine-protein kinase erbB-2 precursor [KO:K05083] [EC:2.7.10.1]
101087287  PDGFA; platelet-derived growth factor subunit A isoform X4 [KO:K04359]
100135774  PDGFB; platelet-derived growth factor subunit B isoform X4 [KO:K17386]
101090765  PDGFRA; platelet-derived growth factor receptor alpha [KO:K04363] [EC:2.7.10.1]
101084600  PDGFRB; platelet-derived growth factor receptor beta isoform X1 [KO:K05089] [EC:2.7.10.1]
101101237  IGF1; insulin-like growth factor I isoform X3 [KO:K05459]
101093644  IGF2; insulin-like growth factor II isoform X3 [KO:K13769]
100500937  IGF1R; insulin-like growth factor 1 receptor isoform X1 [KO:K05087] [EC:2.7.10.1]
493937  KITLG; kit ligand precursor [KO:K05461]
493766  KIT; mast/stem cell growth factor receptor Kit precursor [KO:K05091] [EC:2.7.10.1]
493796  FLT3LG; fms related tyrosine kinase 3 ligand precursor [KO:K05454]
101099264  FLT3; receptor-type tyrosine-protein kinase FLT3 [KO:K05092] [EC:2.7.10.1]
493705  HGF; hepatocyte growth factor precursor [KO:K05460]
493669  MET; hepatocyte growth factor receptor precursor [KO:K05099] [EC:2.7.10.1]
101082206  FGF1; fibroblast growth factor 1 isoform X1 [KO:K18496]
100135772  FGF2; fibroblast growth factor 2 isoform X1 [KO:K18497]
100136904  FGF5; fibroblast growth factor 5 precursor [KO:K04358]
101084335  FGF9; fibroblast growth factor 9 [KO:K04358]
101090606  FGF17; fibroblast growth factor 17 isoform X1 [KO:K04358]
101091459  FGF6; fibroblast growth factor 6 [KO:K04358]
101084778  FGF16; fibroblast growth factor 16 [KO:K04358]
101097982  FGF7; fibroblast growth factor 7 isoform X1 [KO:K04358]
101098518  FGF18; fibroblast growth factor 18 [KO:K04358]
111556546  FGF4; fibroblast growth factor 4 [KO:K04358]
111556666  FGF3; fibroblast growth factor 3 [KO:K04358]
101084652  FGF8; fibroblast growth factor 8 isoform X1 [KO:K04358]
101083745  FGF22; fibroblast growth factor 22 [KO:K04358]
101090489  FGF10; fibroblast growth factor 10 [KO:K04358]
101083766  FGF20; fibroblast growth factor 20 [KO:K04358]
101087099  FGF19; fibroblast growth factor 19 [KO:K22603]
101080595  FGF21; fibroblast growth factor 21 [KO:K22429]
101100063  FGF23; fibroblast growth factor 23 [KO:K22428]
101086055  FGFR1; fibroblast growth factor receptor 1 isoform X1 [KO:K04362] [EC:2.7.10.1]
101095198  FGFR2; fibroblast growth factor receptor 2 isoform X1 [KO:K05093] [EC:2.7.10.1]
100141386  FGFR3; fibroblast growth factor receptor 3 isoform X1 [KO:K05094] [EC:2.7.10.1]
101100864  FGFR4; fibroblast growth factor receptor 4 isoform X5 [KO:K05095] [EC:2.7.10.1]
101099916  GRB2; growth factor receptor-bound protein 2 isoform X1 [KO:K04364]
101098862  SOS1; son of sevenless homolog 1 isoform X1 [KO:K03099]
101088847  SOS2; son of sevenless homolog 2 isoform X1 [KO:K03099]
751103  HRAS; GTPase HRas isoform X1 [KO:K02833]
751104  KRAS; GTPase KRas isoform X2 [KO:K07827]
751105  NRAS; GTPase NRas [KO:K07828]
101089839  ARAF; serine/threonine-protein kinase A-Raf isoform X2 [KO:K08845] [EC:2.7.11.1]
101092346  BRAF; serine/threonine-protein kinase B-raf isoform X5 [KO:K04365] [EC:2.7.11.1]
101096047  RAF1; RAF proto-oncogene serine/threonine-protein kinase isoform X2 [KO:K04366] [EC:2.7.11.1]
101081387  MAP2K1; dual specificity mitogen-activated protein kinase kinase 1 isoform X3 [KO:K04368] [EC:2.7.12.2]
101100281  MAP2K2; dual specificity mitogen-activated protein kinase kinase 2 isoform X1 [KO:K04369] [EC:2.7.12.2]
101087614  MAPK1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]
101087958  MAPK3; mitogen-activated protein kinase 3 isoform X2 [KO:K04371] [EC:2.7.11.24]
101097261  JUN; transcription factor AP-1 [KO:K04448]
493935  FOS; proto-oncogene c-Fos [KO:K04379]
101090461  ETS1; LOW QUALITY PROTEIN: protein C-ets-1 [KO:K02678]
101084217  MMP1; interstitial collagenase [KO:K01388] [EC:3.4.24.7]
101083957  interstitial collagenase-like [KO:K01388] [EC:3.4.24.7]
101098838  MMP2; 72 kDa type IV collagenase [KO:K01398] [EC:3.4.24.24]
101084185  MMP9; matrix metalloproteinase-9 [KO:K01403] [EC:3.4.24.35]
101093854  interleukin-8-like [KO:K10030]
493836  CXCL8; interleukin-8 precursor [KO:K10030]
101097903  CDK4; cyclin-dependent kinase 4 isoform X2 [KO:K02089] [EC:2.7.11.22]
101095179  RPS6KA5; LOW QUALITY PROTEIN: ribosomal protein S6 kinase alpha-5 [KO:K04445] [EC:2.7.11.1]
101101086  RET; proto-oncogene tyrosine-protein kinase receptor Ret [KO:K05126] [EC:2.7.10.1]
101100594  CCDC6; coiled-coil domain-containing protein 6 isoform X1 [KO:K09288]
101094542  NCOA4; nuclear receptor coactivator 4 isoform X2 [KO:K09289]
101081603  NTRK1; high affinity nerve growth factor receptor [KO:K03176] [EC:2.7.10.1]
101099019  TPM3; tropomyosin alpha-3 chain isoform X9 [KO:K09290]
101082873  TPR; nucleoprotein TPR isoform X2 [KO:K09291]
101094042  TFG; protein TFG isoform X1 [KO:K09292]
101094657  RASSF1; ras association domain-containing protein 1 isoform X3 [KO:K09850]
101089486  RASSF5; ras association domain-containing protein 5 isoform X1 [KO:K08015]
101091185  STK4; serine/threonine-protein kinase 4 isoform X1 [KO:K04411]
101099780  DAPK3; death-associated protein kinase 3 [KO:K08803] [EC:2.7.11.1]
101089774  DAPK2; death-associated protein kinase 2 isoform X1 [KO:K08803] [EC:2.7.11.1]
101084322  DAPK1; death-associated protein kinase 1 isoform X1 [KO:K08803] [EC:2.7.11.1]
101092925  PLCG1; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 isoform X1 [KO:K01116] [EC:3.1.4.11]
101080675  PLCG2; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-2 isoform X2 [KO:K05859] [EC:3.1.4.11]
101095156  ELK1; ETS domain-containing protein Elk-1 isoform X1 [KO:K04375]
101081534  CALM2; calmodulin-2 [KO:K02183]
101099307  calmodulin-like protein 3 [KO:K02183]
102902667  calmodulin-like [KO:K02183]
101091063  CALM3; calmodulin-3 [KO:K02183]
101097703  calmodulin-alpha-like [KO:K02183]
101094679  CALM1; calmodulin-1 [KO:K02183]
101086824  CALML6; calmodulin-like protein 6 isoform X1 [KO:K02183]
101100214  CALML4; LOW QUALITY PROTEIN: calmodulin-like protein 4 [KO:K02183]
101098221  CAMK2D; calcium/calmodulin-dependent protein kinase type II subunit delta isoform X4 [KO:K04515] [EC:2.7.11.17]
101098090  CAMK2G; calcium/calmodulin-dependent protein kinase type II subunit gamma isoform X1 [KO:K04515] [EC:2.7.11.17]
101084342  CAMK2A; calcium/calmodulin-dependent protein kinase type II subunit alpha isoform X1 [KO:K04515] [EC:2.7.11.17]
101098615  CAMK2B; calcium/calmodulin-dependent protein kinase type II subunit beta isoform X2 [KO:K04515] [EC:2.7.11.17]
101090558  RALGDS; ral guanine nucleotide dissociation stimulator isoform X2 [KO:K08732]
102899245  ral guanine nucleotide dissociation stimulator-like [KO:K08732]
101091003  RALA; ras-related protein Ral-A [KO:K07834]
101080471  RALB; ras-related protein Ral-B [KO:K07835]
101082017  RALBP1; ralA-binding protein 1 [KO:K08773]
101094772  CDC42; cell division control protein 42 homolog isoform X1 [KO:K04393]
101082454  cell division control protein 42 homolog [KO:K04393]
101101277  RAC1; ras-related C3 botulinum toxin substrate 1 isoform X3 [KO:K04392]
101096744  RAC2; ras-related C3 botulinum toxin substrate 2 isoform X1 [KO:K07860]
101080496  RAC3; ras-related C3 botulinum toxin substrate 3 isoform X1 [KO:K07861]
101084052  PLD1; phospholipase D1 isoform X2 [KO:K01115] [EC:3.1.4.4]
101092214  PLD2; phospholipase D2 [KO:K01115] [EC:3.1.4.4]
101091310  MAPK8; mitogen-activated protein kinase 8 isoform X1 [KO:K04440] [EC:2.7.11.24]
101101463  MAPK10; mitogen-activated protein kinase 10 isoform X3 [KO:K04440] [EC:2.7.11.24]
101084765  MAPK9; mitogen-activated protein kinase 9 isoform X1 [KO:K04440] [EC:2.7.11.24]
101096468  PAX8; paired box protein Pax-8 isoform X3 [KO:K09293]
101095161  PPARG; peroxisome proliferator-activated receptor gamma isoform X1 [KO:K08530]
101085757  RXRA; retinoic acid receptor RXR-alpha isoform X1 [KO:K08524]
101085801  RXRB; retinoic acid receptor RXR-beta isoform X1 [KO:K08525]
101081273  RXRG; retinoic acid receptor RXR-gamma isoform X2 [KO:K08526]
101085742  RARB; retinoic acid receptor beta isoform X2 [KO:K08528]
552888  ESR1; estrogen receptor [KO:K08550]
101086317  ESR2; estrogen receptor beta [KO:K08551]
101094588  NCOA1; nuclear receptor coactivator 1 isoform X1 [KO:K09101] [EC:2.3.1.48]
101083330  NCOA3; nuclear receptor coactivator 3 isoform X1 [KO:K11256] [EC:2.3.1.48]
101100227  SP1; transcription factor Sp1 [KO:K04684]
101098383  PPARD; peroxisome proliferator-activated receptor delta isoform X1 [KO:K04504]
101092310  JUP; junction plakoglobin [KO:K10056]
101098251  ZBTB16; zinc finger and BTB domain-containing protein 16 [KO:K10055]
101083048  RARA; retinoic acid receptor alpha isoform X2 [KO:K08527]
101088573  CCNA2; cyclin-A2 [KO:K06627]
101085426  CCNA1; cyclin-A1 isoform X1 [KO:K06627]
101086975  PML; protein PML isoform X1 [KO:K10054] [EC:2.3.2.-]
101084898  RUNX1; runt-related transcription factor 1 isoform X1 [KO:K08367]
101080942  RUNX1T1; protein CBFA2T1 isoform X1 [KO:K10053]
101094951  SPI1; transcription factor PU.1 isoform X4 [KO:K09438]
105261262  CEBPA; CCAAT/enhancer-binding protein alpha [KO:K09055]
101100621  granulocyte-macrophage colony-stimulating factor receptor subunit alpha isoform X1 [KO:K05066]
102901718  granulocyte-macrophage colony-stimulating factor receptor subunit alpha-like isoform X1 [KO:K05066]
101089787  CSF3R; granulocyte colony-stimulating factor receptor isoform X1 [KO:K05061]
493706  CSF1R; macrophage colony-stimulating factor 1 receptor precursor [KO:K05090] [EC:2.7.10.1]
101089220  CDKN2A; cyclin-dependent kinase inhibitor 2A [KO:K06621]
101098454  E2F1; transcription factor E2F1 isoform X3 [KO:K17454]
101098067  E2F2; transcription factor E2F2 [KO:K09389]
101089768  E2F3; transcription factor E2F3 isoform X3 [KO:K06620]
493947  MAX; protein max [KO:K04453]
101084723  ZBTB17; zinc finger and BTB domain-containing protein 17 isoform X1 [KO:K10500]
101087014  CDKN2B; cyclin-dependent kinase 4 inhibitor B [KO:K04685]
100037415  CDK6; cyclin-dependent kinase 6 [KO:K02091] [EC:2.7.11.22]
101090950  CCND2; G1/S-specific cyclin-D2 [KO:K10151]
101101311  CCND3; G1/S-specific cyclin-D3 isoform X1 [KO:K10152]
101092660  CKS1B; cyclin-dependent kinases regulatory subunit 1 [KO:K02219]
101086011  CKS2; cyclin-dependent kinases regulatory subunit 2 [KO:K02219]
101099017  SKP1; S-phase kinase-associated protein 1 [KO:K03094]
101084045  S-phase kinase-associated protein 1-like [KO:K03094]
101087051  CUL1; cullin-1 isoform X3 [KO:K03347]
101087758  RBX1; E3 ubiquitin-protein ligase RBX1 [KO:K03868] [EC:2.3.2.32]
101099275  SKP2; S-phase kinase-associated protein 2 isoform X2 [KO:K03875]
101093368  CDK2; cyclin-dependent kinase 2 isoform X2 [KO:K02206] [EC:2.7.11.22]
101086192  CCNE1; G1/S-specific cyclin-E1 isoform X1 [KO:K06626]
101085347  CCNE2; G1/S-specific cyclin-E2 isoform X1 [KO:K06626]
101101356  RB1; retinoblastoma-associated protein isoform X1 [KO:K06618]
101087971  GADD45B; growth arrest and DNA damage-inducible protein GADD45 beta [KO:K04402]
101086509  GADD45G; growth arrest and DNA damage-inducible protein GADD45 gamma [KO:K04402]
493837  BAX; apoptosis regulator BAX [KO:K02159]
101093435  BAK1; bcl-2 homologous antagonist/killer [KO:K14021]
101092211  DDB2; DNA damage-binding protein 2 isoform X1 [KO:K10140]
101099613  POLK; DNA polymerase kappa isoform X1 [KO:K03511] [EC:2.7.7.7]
100144612  TERT; telomerase reverse transcriptase isoform X1 [KO:K11126] [EC:2.7.7.49]
101091431  MITF; microphthalmia-associated transcription factor isoform X7 [KO:K09455]
768263  TGFB1; transforming growth factor beta-1 proprotein isoform X2 [KO:K13375]
101093414  TGFB2; transforming growth factor beta-2 proprotein isoform X2 [KO:K13376]
101098469  TGFB3; transforming growth factor beta-3 proprotein [KO:K13377]
101094057  TGFBR1; TGF-beta receptor type-1 isoform X1 [KO:K04674] [EC:2.7.11.30]
101091725  TGFBR2; TGF-beta receptor type-2 isoform X2 [KO:K04388] [EC:2.7.11.30]
101087179  SMAD2; mothers against decapentaplegic homolog 2 isoform X1 [KO:K04500]
101101387  SMAD3; mothers against decapentaplegic homolog 3 isoform X1 [KO:K23605]
101093650  SMAD4; mothers against decapentaplegic homolog 4 isoform X1 [KO:K04501]
101088775  MECOM; histone-lysine N-methyltransferase MECOM isoform X2 [KO:K04462] [EC:2.1.1.367]
101095494  CTBP1; C-terminal-binding protein 1 isoform X2 [KO:K04496] [EC:1.1.1.428]
101099152  CTBP2; C-terminal-binding protein 2 isoform X1 [KO:K04496] [EC:1.1.1.428]
101088165  HDAC2; histone deacetylase 2 isoform X1 [KO:K06067] [EC:3.5.1.98]
101099228  HDAC1; histone deacetylase 1 isoform X3 [KO:K06067] [EC:3.5.1.98]
101089037  MLH1; DNA mismatch repair protein Mlh1 isoform X1 [KO:K08734]
101082051  MSH2; DNA mismatch repair protein Msh2 [KO:K08735]
101090919  MSH3; DNA mismatch repair protein Msh3 isoform X1 [KO:K08736]
101082303  MSH6; DNA mismatch repair protein Msh6 isoform X1 [KO:K08737]
493878  BRCA2; breast cancer type 2 susceptibility protein homolog [KO:K08775]
101089015  RAD51; DNA repair protein RAD51 homolog 1 [KO:K04482]
493945  FASLG; tumor necrosis factor ligand superfamily member 6 [KO:K04389]
493881  FAS; tumor necrosis factor receptor superfamily member 6 precursor [KO:K04390]
101087871  FADD; FAS-associated death domain protein [KO:K02373]
100142684  CASP8; caspase-8 [KO:K04398] [EC:3.4.22.61]
100502578  BID; BH3-interacting domain death agonist [KO:K04726]
102900397  PMAIP1; phorbol-12-myristate-13-acetate-induced protein 1 [KO:K10131]
111558033  BBC3; bcl-2-binding component 3 [KO:K10132]
101084615  BCL2L11; bcl-2-like protein 11 isoform X6 [KO:K16341]
101098213  cytochrome c [KO:K08738]
101088122  cytochrome c-like [KO:K08738]
101100947  cytochrome c [KO:K08738]
101088339  cytochrome c-like [KO:K08738]
109503558  cytochrome c-like [KO:K08738]
768257  APAF1; apoptotic protease-activating factor 1 isoform X1 [KO:K02084]
768262  CASP7; caspase-7 isoform X2 [KO:K04397] [EC:3.4.22.60]
101091260  KEAP1; kelch-like ECH-associated protein 1 [KO:K10456]
101098812  NFE2L2; nuclear factor erythroid 2-related factor 2 isoform X2 [KO:K05638]
101092621  HMOX1; heme oxygenase 1 [KO:K00510] [EC:1.14.14.18]
101097859  NQO1; NAD(P)H dehydrogenase [quinone] 1 isoform X1 [KO:K00355] [EC:1.6.5.2]
101090936  MGST2; microsomal glutathione S-transferase 2 isoform X1 [KO:K00799] [EC:2.5.1.18]
101096317  glutathione S-transferase A2 [KO:K00799] [EC:2.5.1.18]
101097351  GSTO1; glutathione S-transferase omega-1 isoform X2 [KO:K00799] [EC:2.5.1.18]
101099565  MGST1; microsomal glutathione S-transferase 1 isoform X2 [KO:K00799] [EC:2.5.1.18]
101090141  GSTO2; glutathione S-transferase omega-2 isoform X1 [KO:K00799] [EC:2.5.1.18]
101080760  MGST3; microsomal glutathione S-transferase 3 [KO:K00799] [EC:2.5.1.18]
100169963  GSTM3; glutathione S-transferase Mu 3 [KO:K00799] [EC:2.5.1.18]
101083114  glutathione S-transferase theta-3-like isoform X1 [KO:K00799] [EC:2.5.1.18]
101083370  glutathione S-transferase theta-1 isoform X1 [KO:K00799] [EC:2.5.1.18]
101092550  glutathione S-transferase theta-1-like [KO:K00799] [EC:2.5.1.18]
101085041  GSTA4; glutathione S-transferase A4 [KO:K00799] [EC:2.5.1.18]
101092798  LOW QUALITY PROTEIN: glutathione S-transferase theta-2B-like [KO:K00799] [EC:2.5.1.18]
101100824  glutathione S-transferase Mu 4 [KO:K00799] [EC:2.5.1.18]
101084793  glutathione S-transferase A4-like isoform X1 [KO:K00799] [EC:2.5.1.18]
101083623  glutathione S-transferase theta-4-like [KO:K00799] [EC:2.5.1.18]
101082184  GSTP1; glutathione S-transferase P isoform X1 [KO:K23790] [EC:2.5.1.18]
101085222  TXNRD1; thioredoxin reductase 1, cytoplasmic isoform X3 [KO:K22182] [EC:1.8.1.9]
101090928  TXNRD3; thioredoxin reductase 3 [KO:K22182] [EC:1.8.1.9]
101101420  TXNRD2; thioredoxin reductase 2, mitochondrial isoform X3 [KO:K22182] [EC:1.8.1.9]
101092590  VHL; von Hippel-Lindau disease tumor suppressor isoform X1 [KO:K03871]
100628309  ELOC; elongin-C [KO:K03872]
101098462  elongin-C-like [KO:K03872]
100628310  TCEB2; transcription elongation factor B polypeptide 2 [KO:K03873]
101101182  ELOB; elongin-B isoform X2 [KO:K03873]
101094429  CUL2; cullin-2 isoform X1 [KO:K03870]
101090063  EGLN2; prolyl hydroxylase EGLN2 [KO:K09592] [EC:1.14.11.29]
101082320  EGLN3; prolyl hydroxylase EGLN3 [KO:K09592] [EC:1.14.11.29]
101089964  EGLN1; egl nine homolog 1 isoform X1 [KO:K09592] [EC:1.14.11.29]
101096029  FH; fumarate hydratase, mitochondrial [KO:K01679] [EC:4.2.1.2]
101083686  HIF1A; hypoxia-inducible factor 1-alpha [KO:K08268]
101085621  EPAS1; endothelial PAS domain-containing protein 1 isoform X1 [KO:K09095]
101093627  ARNT; aryl hydrocarbon receptor nuclear translocator isoform X2 [KO:K09097]
101087746  ARNT2; aryl hydrocarbon receptor nuclear translocator 2 isoform X3 [KO:K15589]
101088344  EP300; histone acetyltransferase p300 isoform X2 [KO:K04498] [EC:2.3.1.48]
101094471  CREBBP; CREB-binding protein isoform X1 [KO:K04498] [EC:2.3.1.48]
100127104  SLC2A1; solute carrier family 2, facilitated glucose transporter member 1 [KO:K07299]
101093427  JAG1; protein jagged-1 isoform X1 [KO:K06052]
101089198  JAG2; protein jagged-2 isoform X1 [KO:K21635]
101086978  DLL4; delta-like protein 4 [KO:K06051]
101095456  DLL3; delta-like protein 3 isoform X1 [KO:K06051]
101083683  DLL1; delta-like protein 1 [KO:K06051]
101094384  NOTCH1; neurogenic locus notch homolog protein 1 isoform X2 [KO:K02599]
101091800  NOTCH2; neurogenic locus notch homolog protein 2 isoform X1 [KO:K20994]
101088469  NOTCH3; neurogenic locus notch homolog protein 3 [KO:K20995]
101080381  NOTCH4; neurogenic locus notch homolog protein 4 isoform X1 [KO:K20996]
105260569  neurogenic locus notch homolog protein 4-like isoform X1 [KO:K20996]
101091223  HES1; transcription factor HES-1 [KO:K06054]
101089627  HES5; transcription factor HES-5 [KO:K06055]
101083681  HEY2; hairy/enhancer-of-split related with YRPW motif protein 2 isoform X1 [KO:K09091]
101085436  HEY1; hairy/enhancer-of-split related with YRPW motif protein 1 isoform X1 [KO:K09091]
101089629  HEYL; hairy/enhancer-of-split related with YRPW motif-like protein [KO:K09091]
101094727  FLT4; vascular endothelial growth factor receptor 3 isoform X3 [KO:K05097] [EC:2.7.10.1]
111557492  SHH; sonic hedgehog protein [KO:K11988]
101085077  PTCH1; protein patched homolog 1 isoform X2 [KO:K06225]
101087567  SMO; smoothened homolog isoform X1 [KO:K06226]
101090619  KIF7; kinesin-like protein KIF7 isoform X1 [KO:K18806]
101085156  SUFU; suppressor of fused homolog isoform X4 [KO:K06229]
101092697  GLI1; zinc finger protein GLI1 isoform X2 [KO:K16797]
101101401  GLI2; zinc finger protein GLI2 isoform X1 [KO:K16798]
101089998  GLI3; transcriptional activator GLI3 isoform X3 [KO:K06230]
100301987  BMP2; bone morphogenetic protein 2 isoform X2 [KO:K21283]
101100311  BMP4; bone morphogenetic protein 4 isoform X2 [KO:K04662]
101087058  HHIP; hedgehog-interacting protein [KO:K06231]
101089126  PTCH2; protein patched homolog 2 isoform X4 [KO:K11101]
101081787  AR; androgen receptor isoform X1 [KO:K08557]
101095825  HSP90AB1; heat shock protein HSP 90-beta [KO:K04079]
101094857  HSP90AA1; heat shock protein HSP 90-alpha [KO:K04079]
101082249  HSP90B1; endoplasmin [KO:K09487]
Compound
C00027  Hydrogen peroxide
C00039  DNA
C00076  Calcium cation
C00122  Fumarate
C00149  (S)-Malate
C00165  Diacylglycerol
C00187  Cholesterol
C00280  Androstenedione
C00410  Progesterone
C00416  Phosphatidate
C00533  Nitric oxide
C00535  Testosterone
C00575  3',5'-Cyclic AMP
C00584  Prostaglandin E2
C00681  1-Acyl-sn-glycerol 3-phosphate
C00704  Superoxide
C00735  Cortisol
C00762  Cortisone
C00777  Retinoate
C00951  Estradiol-17beta
C01227  Dehydroepiandrosterone
C01245  D-myo-Inositol 1,4,5-trisphosphate
C01471  Acrolein
C03917  Dihydrotestosterone
C05981  Phosphatidylinositol-3,4,5-trisphosphate
C07653  Flutamide
C15493  9-cis-Retinoic acid
C16038  2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine
C16844  Hydroxyl radical
C21641  Hydroperoxyl radical
C21642  4-Hydroxynonenal
Reference
  Authors
Weinberg RA.
  Title
The biology of cancer
  Journal
Garland Science, Taylor & Francis Group, LLC (2007)
Reference
PMID:10647931
  Authors
Hanahan D, Weinberg RA
  Title
The hallmarks of cancer.
  Journal
Cell 100:57-70 (2000)
DOI:10.1016/S0092-8674(00)81683-9
Reference
PMID:15000146
  Authors
Grady WM.
  Title
Genomic instability and colon cancer.
  Journal
Cancer Metastasis Rev 23:11-27 (2004)
DOI:10.1023/A:1025861527711
Reference
PMID:16555243
  Authors
Soreide K, Janssen EA, Soiland H, Korner H, Baak JP.
  Title
Microsatellite instability in colorectal cancer.
  Journal
Br J Surg 93:395-406 (2006)
DOI:10.1002/bjs.5328
Reference
PMID:11078609
  Authors
Anwar S, Hall C, White J, Deakin M, Farrell W, Elder JB.
  Title
Hereditary non-polyposis colorectal cancer: an updated review.
  Journal
Eur J Surg Oncol 26:635-45 (2000)
DOI:10.1053/ejso.2000.0974
Reference
PMID:16699851
  Authors
Takayama T, Miyanishi K, Hayashi T, Sato Y, Niitsu Y.
  Title
Colorectal cancer: genetics of development and metastasis.
  Journal
J Gastroenterol 41:185-92 (2006)
DOI:10.1007/s00535-006-1801-6
Reference
PMID:12621137
  Authors
Lynch HT, de la Chapelle A.
  Title
Hereditary colorectal cancer.
  Journal
N Engl J Med 348:919-32 (2003)
DOI:10.1056/NEJMra012242
Reference
PMID:12951588
  Authors
Rajagopalan H, Nowak MA, Vogelstein B, Lengauer C.
  Title
The significance of unstable chromosomes in colorectal cancer.
  Journal
Nat Rev Cancer 3:695-701 (2003)
DOI:10.1038/nrc1165
Reference
PMID:10505543
  Authors
Behrens J.
  Title
Cadherins and catenins: role in signal transduction and tumor progression.
  Journal
Cancer Metastasis Rev 18:15-30 (1999)
DOI:10.1023/A:1006200102166
Reference
PMID:16042571
  Authors
Behrens J.
  Title
The role of the Wnt signalling pathway in colorectal tumorigenesis.
  Journal
Biochem Soc Trans 33:672-5 (2005)
DOI:10.1042/BST0330672
Reference
PMID:15349822
  Authors
Behrens J, Lustig B.
  Title
The Wnt connection to tumorigenesis.
  Journal
Int J Dev Biol 48:477-87 (2004)
DOI:10.1387/ijdb.041815jb
Reference
PMID:9196022
  Authors
Polakis P.
  Title
The adenomatous polyposis coli (APC) tumor suppressor.
  Journal
Biochim Biophys Acta 1332:F127-47 (1997)
DOI:10.1016/S0304-419X(97)00008-5
Reference
PMID:12737309
  Authors
Janssen KP.
  Title
Murine models of colorectal cancer: studying the role of oncogenic K-ras.
  Journal
Cell Mol Life Sci 60:495-506 (2003)
DOI:10.1007/s000180300041
Reference
PMID:11459867
  Authors
Adjei AA.
  Title
Blocking oncogenic Ras signaling for cancer therapy.
  Journal
J Natl Cancer Inst 93:1062-74 (2001)
DOI:10.1093/jnci/93.14.1062
Reference
PMID:15573119
  Authors
Arakawa H.
  Title
Netrin-1 and its receptors in tumorigenesis.
  Journal
Nat Rev Cancer 4:978-87 (2004)
DOI:10.1038/nrc1504
Reference
PMID:15310786
  Authors
Mehlen P, Fearon ER.
  Title
Role of the dependence receptor DCC in colorectal cancer pathogenesis.
  Journal
J Clin Oncol 22:3420-8 (2004)
DOI:10.1200/JCO.2004.02.019
Reference
PMID:11223406
  Authors
Peltomaki P.
  Title
DNA mismatch repair and cancer.
  Journal
Mutat Res 488:77-85 (2001)
DOI:10.1016/S1383-5742(00)00058-2
Reference
PMID:15711891
  Authors
Li F, Cao Y, Townsend CM Jr, Ko TC.
  Title
TGF-beta signaling in colon cancer cells.
  Journal
World J Surg 29:306-11 (2005)
DOI:10.1007/s00268-004-7813-6
Reference
PMID:11170304
  Authors
Roman C, Saha D, Beauchamp R.
  Title
TGF-beta and colorectal carcinogenesis.
  Journal
Microsc Res Tech 52:450-7 (2001)
DOI:10.1002/1097-0029(20010215)52:4<450::AID-JEMT1030>3.0.CO;2-O
Reference
PMID:16326109
  Authors
Watson AJ.
  Title
An overview of apoptosis and the prevention of colorectal cancer.
  Journal
Crit Rev Oncol Hematol 57:107-21 (2006)
DOI:10.1016/j.critrevonc.2005.06.005
Reference
PMID:15479695
  Authors
Watson AJ.
  Title
Apoptosis and colorectal cancer.
  Journal
Gut 53:1701-9 (2004)
DOI:10.1136/gut.2004.052704
Reference
PMID:11477132
  Authors
Houlston RS.
  Title
What we could do now: molecular pathology of colorectal cancer.
  Journal
Mol Pathol 54:206-14 (2001)
DOI:10.1136/mp.54.4.206
Reference
  Authors
Von Hoff D, Evans D, Hruban R (ed).
  Title
Pancreatic cancer
  Journal
Jones and Bartlett publishers (2005)
Reference
  Authors
Niitsu Y, Yokota J (ed).
  Title
[Oncogenes and Tumor Suppressor Genes for Medical Oncologist] (In Japanese)
  Journal
Nankodo (1999)
Reference
PMID:12459728
  Authors
Bardeesy N, DePinho RA.
  Title
Pancreatic cancer biology and genetics.
  Journal
Nat Rev Cancer 2:897-909 (2002)
DOI:10.1038/nrc949
Reference
PMID:11407945
  Authors
Bardeesy N, Sharpless NE, DePinho RA, Merlino G.
  Title
The genetics of pancreatic adenocarcinoma: a roadmap for a mouse model.
  Journal
Semin Cancer Biol 11:201-18 (2001)
DOI:10.1006/scbi.2000.0371
Reference
PMID:12946833
  Authors
Cowgill SM, Muscarella P.
  Title
The genetics of pancreatic cancer.
  Journal
Am J Surg 186:279-86 (2003)
DOI:10.1016/S0002-9610(03)00226-5
Reference
PMID:16702400
  Authors
Hezel AF, Kimmelman AC, Stanger BZ, Bardeesy N, Depinho RA.
  Title
Genetics and biology of pancreatic ductal adenocarcinoma.
  Journal
Genes Dev 20:1218-49 (2006)
DOI:10.1101/gad.1415606
Reference
PMID:10740269
  Authors
Shields JM, Pruitt K, McFall A, Shaub A, Der CJ.
  Title
Understanding Ras: 'it ain't over 'til it's over'.
  Journal
Trends Cell Biol 10:147-54 (2000)
DOI:10.1016/S0962-8924(00)01740-2
Reference
PMID:12648469
  Authors
Holbro T, Civenni G, Hynes NE.
  Title
The ErbB receptors and their role in cancer progression.
  Journal
Exp Cell Res 284:99-110 (2003)
DOI:10.1016/S0014-4827(02)00099-X
Reference
PMID:14967450
  Authors
Marmor MD, Skaria KB, Yarden Y.
  Title
Signal transduction and oncogenesis by ErbB/HER receptors.
  Journal
Int J Radiat Oncol Biol Phys 58:903-13 (2004)
DOI:10.1016/j.ijrobp.2003.06.002
Reference
PMID:14586404
  Authors
DeArmond D, Brattain MG, Jessup JM, Kreisberg J, Malik S, Zhao S, Freeman JW.
  Title
Autocrine-mediated ErbB-2 kinase activation of STAT3 is required for growth factor independence of pancreatic cancer cell lines.
  Journal
Oncogene 22:7781-95 (2003)
DOI:10.1038/sj.onc.1206966
Reference
PMID:12545153
  Authors
Wei D, Le X, Zheng L, Wang L, Frey JA, Gao AC, Peng Z, Huang S, Xiong HQ, Abbruzzese JL, Xie K.
  Title
Stat3 activation regulates the expression of vascular endothelial growth factor and human pancreatic cancer angiogenesis and metastasis.
  Journal
Oncogene 22:319-29 (2003)
DOI:10.1038/sj.onc.1206122
Reference
PMID:14580692
  Authors
Toyonaga T, Nakano K, Nagano M, Zhao G, Yamaguchi K, Kuroki S, Eguchi T, Chijiiwa K, Tsuneyoshi M, Tanaka M.
  Title
Blockade of constitutively activated Janus kinase/signal transducer and activator of transcription-3 pathway inhibits growth of human pancreatic cancer.
  Journal
Cancer Lett 201:107-16 (2003)
DOI:10.1016/S0304-3835(03)00482-8
Reference
PMID:12079267
  Authors
Schmid RM.
  Title
Genetic basis of pancreatic cancer.
  Journal
Best Pract Res Clin Gastroenterol 16:421-33 (2002)
DOI:10.1053/bega.2002.0316
Reference
PMID:15774796
  Authors
Elliott RL, Blobe GC.
  Title
Role of transforming growth factor Beta in human cancer.
  Journal
J Clin Oncol 23:2078-93 (2005)
DOI:10.1200/JCO.2005.02.047
Reference
PMID:15823750
  Authors
Rudkin TM, Foulkes WD.
  Title
BRCA2: breaks, mistakes and failed separations.
  Journal
Trends Mol Med 11:145-8 (2005)
DOI:10.1016/j.molmed.2005.02.003
Reference
PMID:11707511
  Authors
Venkitaraman AR.
  Title
Functions of BRCA1 and BRCA2 in the biological response to DNA damage.
  Journal
J Cell Sci 114:3591-8 (2001)
Reference
PMID:15639402
  Authors
Soni D, King JA, Kaye AH, Hovens CM.
  Title
Genetics of glioblastoma multiforme: mitogenic signaling and cell cycle pathways converge.
  Journal
J Clin Neurosci 12:1-5 (2005)
DOI:10.1016/j.jocn.2004.04.001
Reference
PMID:12154354
  Authors
Zhu Y, Parada LF.
  Title
The molecular and genetic basis of neurological tumours.
  Journal
Nat Rev Cancer 2:616-26 (2002)
DOI:10.1038/nrc866
Reference
PMID:11253051
  Authors
Holland EC.
  Title
Gliomagenesis: genetic alterations and mouse models.
  Journal
Nat Rev Genet 2:120-9 (2001)
DOI:10.1038/35052535
Reference
PMID:16700615
  Authors
Bansal K, Liang ML, Rutka JT.
  Title
Molecular biology of human gliomas.
  Journal
Technol Cancer Res Treat 5:185-94 (2006)
DOI:10.1177/153303460600500302
Reference
  Authors
Tabuchi K (ed).
  Title
[Gliomas: Research and therapy] (In Japanese)
  Journal
Springer-Verlag Tokyo (2006)
Reference
PMID:12762887
  Authors
Kapoor GS, O'Rourke DM.
  Title
Mitogenic signaling cascades in glial tumors.
  Journal
Neurosurgery 52:1425-34; discussion 1434-5 (2003)
DOI:10.1227/01.NEU.0000065135.28143.39
Reference
PMID:16095998
  Authors
Hulleman E, Helin K.
  Title
Molecular mechanisms in gliomagenesis.
  Journal
Adv Cancer Res 94:1-27 (2005)
DOI:10.1016/S0065-230X(05)94001-3
Reference
PMID:11057895
  Authors
Schlessinger J.
  Title
Cell signaling by receptor tyrosine kinases.
  Journal
Cell 103:211-25 (2000)
DOI:10.1016/S0092-8674(00)00114-8
Reference
PMID:9643506
  Authors
Ng HK, Lam PY.
  Title
The molecular genetics of central nervous system tumors.
  Journal
Pathology 30:196-202 (1998)
DOI:10.1080/00313029800169236
Reference
PMID:12084351
  Authors
Knobbe CB, Merlo A, Reifenberger G.
  Title
Pten signaling in gliomas.
  Journal
Neuro-oncol 4:196-211 (2002)
DOI:10.1093/neuonc/4.3.196
Reference
PMID:16557281
  Authors
Kondo T, Ezzat S, Asa SL.
  Title
Pathogenetic mechanisms in thyroid follicular-cell neoplasia.
  Journal
Nat Rev Cancer 6:292-306 (2006)
DOI:10.1038/nrc1836
Reference
PMID:16551846
  Authors
Chiloeches A, Marais R.
  Title
Is BRAF the Achilles' Heel of thyroid cancer?
  Journal
Clin Cancer Res 12:1661-4 (2006)
DOI:10.1158/1078-0432.CCR-06-0051
Reference
PMID:16946003
  Authors
Reddi HV, McIver B, Grebe SK, Eberhardt NL
  Title
The paired box-8/peroxisome proliferator-activated receptor-gamma oncogene in thyroid tumorigenesis.
  Journal
Endocrinology 148:932-5 (2007)
DOI:10.1210/en.2006-0926
Reference
PMID:17062879
  Authors
Santoro M, Melillo RM, Fusco A.
  Title
RET/PTC activation in papillary thyroid carcinoma: European Journal of Endocrinology Prize Lecture.
  Journal
Eur J Endocrinol 155:645-653 (2006)
DOI:10.1530/eje.1.02289
Reference
PMID:16242838
  Authors
Pierotti MA, Greco A.
  Title
Oncogenic rearrangements of the NTRK1/NGF receptor.
  Journal
Cancer Lett 232:90-8 (2006)
DOI:10.1016/j.canlet.2005.07.043
Reference
PMID:16189702
  Authors
Sobrinho-Simoes M, Preto A, Rocha AS, Castro P, Maximo V, Fonseca E, Soares P.
  Title
Molecular pathology of well-differentiated thyroid carcinomas.
  Journal
Virchows Arch 447:787-93 (2005)
DOI:10.1007/s00428-005-0065-5
Reference
PMID:11165748
  Authors
Gimm O.
  Title
Thyroid cancer.
  Journal
Cancer Lett 163:143-56 (2001)
DOI:10.1016/S0304-3835(00)00697-2
Reference
PMID:12094241
  Authors
Williams D.
  Title
Cancer after nuclear fallout: lessons from the Chernobyl accident.
  Journal
Nat Rev Cancer 2:543-9 (2002)
DOI:10.1038/nrc845
Reference
PMID:16236521
  Authors
Steffen B, Muller-Tidow C, Schwable J, Berdel WE, Serve H.
  Title
The molecular pathogenesis of acute myeloid leukemia.
  Journal
Crit Rev Oncol Hematol 56:195-221 (2005)
DOI:10.1016/j.critrevonc.2004.10.012
Reference
PMID:12563308
  Authors
Tenen DG.
  Title
Disruption of differentiation in human cancer: AML shows the way.
  Journal
Nat Rev Cancer 3:89-101 (2003)
DOI:10.1038/nrc989
Reference
PMID:16146838
  Authors
Choudhary C, Muller-Tidow C, Berdel WE, Serve H.
  Title
Signal transduction of oncogenic Flt3.
  Journal
Int J Hematol 82:93-9 (2005)
DOI:10.1532/IJH97.05090
Reference
PMID:12951584
  Authors
Stirewalt DL, Radich JP.
  Title
The role of FLT3 in haematopoietic malignancies.
  Journal
Nat Rev Cancer 3:650-65 (2003)
DOI:10.1038/nrc1169
Reference
PMID:16642045
  Authors
Martelli AM, Nyakern M, Tabellini G, Bortul R, Tazzari PL, Evangelisti C, Cocco L.
  Title
Phosphoinositide 3-kinase/Akt signaling pathway and its therapeutical implications for human acute myeloid leukemia.
  Journal
Leukemia 20:911-28 (2006)
DOI:10.1038/sj.leu.2404245
Reference
PMID:15625120
  Authors
Lennartsson J, Jelacic T, Linnekin D, Shivakrupa R.
  Title
Normal and oncogenic forms of the receptor tyrosine kinase kit.
  Journal
Stem Cells 23:16-43 (2005)
DOI:10.1634/stemcells.2004-0117
Reference
PMID:11721960
  Authors
Lorsbach RB, Downing JR.
  Title
The role of the AML1 transcription factor in leukemogenesis.
  Journal
Int J Hematol 74:258-65 (2001)
DOI:10.1007/BF02982058
Reference
PMID:12468433
  Authors
Mizuki M, Schwable J, Steur C, Choudhary C, Agrawal S, Sargin B, Steffen B, Matsumura I, Kanakura Y, Bohmer FD, Muller-Tidow C, Berdel WE, Serve H.
  Title
Suppression of myeloid transcription factors and induction of STAT response genes by AML-specific Flt3 mutations.
  Journal
Blood 101:3164-73 (2003)
DOI:10.1182/blood-2002-06-1677
Reference
PMID:17554387
  Authors
Mikesch JH, Steffen B, Berdel WE, Serve H, Muller-Tidow C.
  Title
The emerging role of Wnt signaling in the pathogenesis of acute myeloid leukemia.
  Journal
Leukemia 21:1638-47 (2007)
DOI:10.1038/sj.leu.2404732
Reference
PMID:16352814
  Authors
Mueller BU, Pabst T, Fos J, Petkovic V, Fey MF, Asou N, Buergi U, Tenen DG.
  Title
ATRA resolves the differentiation block in t(15;17) acute myeloid leukemia by restoring PU.1 expression.
  Journal
Blood 107:3330-8 (2006)
DOI:10.1182/blood-2005-07-3068
Reference
PMID:15719031
  Authors
Ren R.
  Title
Mechanisms of BCR-ABL in the pathogenesis of chronic myelogenous leukaemia.
  Journal
Nat Rev Cancer 5:172-83 (2005)
DOI:10.1038/nrc1567
Reference
PMID:11071626
  Authors
Deininger MW, Goldman JM, Melo JV.
  Title
The molecular biology of chronic myeloid leukemia.
  Journal
Blood 96:3343-56 (2000)
Reference
PMID:14982876
  Authors
Calabretta B, Perrotti D.
  Title
The biology of CML blast crisis.
  Journal
Blood 103:4010-22 (2004)
DOI:10.1182/blood-2003-12-4111
Reference
PMID:10403855
  Authors
Faderl S, Talpaz M, Estrov Z, O'Brien S, Kurzrock R, Kantarjian HM.
  Title
The biology of chronic myeloid leukemia.
  Journal
N Engl J Med 341:164-72 (1999)
DOI:10.1056/NEJM199907153410306
Reference
PMID:15156182
  Authors
Mitani K.
  Title
Molecular mechanisms of leukemogenesis by AML1/EVI-1.
  Journal
Oncogene 23:4263-9 (2004)
DOI:10.1038/sj.onc.1207777
Reference
PMID:16484590
  Authors
Dong M, Blobe GC.
  Title
Role of transforming growth factor-beta in hematologic malignancies.
  Journal
Blood 107:4589-96 (2006)
DOI:10.1182/blood-2005-10-4169
Reference
PMID:9834202
  Authors
Kurokawa M, Mitani K, Imai Y, Ogawa S, Yazaki Y, Hirai H.
  Title
The t(3;21) fusion product, AML1/Evi-1, interacts with Smad3 and blocks transforming growth factor-beta-mediated growth inhibition of myeloid cells.
  Journal
Blood 92:4003-12 (1998)
Reference
PMID:12801837
  Authors
Brusa G, Benvenuti M, Mazzacurati L, Mancini M, Pattacini L, Martinelli G, Barbieri E, Greenberger JS, Baccarani M, Santucci MA.
  Title
p53 loss of function enhances genomic instability and accelerates clonal evolution of murine myeloid progenitors expressing the p(210)BCR-ABL tyrosine kinase.
  Journal
Haematologica 88:622-30 (2003)
Reference
PMID:11160144
  Authors
Baldwin AS.
  Title
Control of oncogenesis and cancer therapy resistance by the transcription factor NF-kappaB.
  Journal
J Clin Invest 107:241-6 (2001)
DOI:10.1172/JCI11991
Reference
PMID:12244301
  Authors
Shin I, Yakes FM, Rojo F, Shin NY, Bakin AV, Baselga J, Arteaga CL.
  Title
PKB/Akt mediates cell-cycle progression by phosphorylation of p27(Kip1) at threonine 157 and modulation of its cellular localization.
  Journal
Nat Med 8:1145-52 (2002)
DOI:10.1038/nm759
Reference
PMID:15948971
  Authors
Tilli CM, Van Steensel MA, Krekels GA, Neumann HA, Ramaekers FC.
  Title
Molecular aetiology and pathogenesis of basal cell carcinoma.
  Journal
Br J Dermatol 152:1108-24 (2005)
DOI:10.1111/j.1365-2133.2005.06587.x
Reference
PMID:12588368
  Authors
Saldanha G, Fletcher A, Slater DN.
  Title
Basal cell carcinoma: a dermatopathological and molecular biological update.
  Journal
Br J Dermatol 148:195-202 (2003)
DOI:10.1046/j.1365-2133.2003.05151.x
Reference
PMID:15978322
  Authors
Daya-Grosjean L, Couve-Privat S.
  Title
Sonic hedgehog signaling in basal cell carcinomas.
  Journal
Cancer Lett 225:181-92 (2005)
DOI:10.1016/j.canlet.2004.10.003
Reference
PMID:15468170
  Authors
Tsai KY, Tsao H.
  Title
The genetics of skin cancer.
  Journal
Am J Med Genet C Semin Med Genet 131C:82-92 (2004)
DOI:10.1002/ajmg.c.30037
Reference
PMID:16881963
  Authors
Athar M, Tang X, Lee JL, Kopelovich L, Kim AL.
  Title
Hedgehog signalling in skin development and cancer.
  Journal
Exp Dermatol 15:667-77 (2006)
DOI:10.1111/j.1600-0625.2006.00473.x
Reference
PMID:16306523
  Authors
Rubin AI, Chen EH, Ratner D.
  Title
Basal-cell carcinoma.
  Journal
N Engl J Med 353:2262-9 (2005)
DOI:10.1056/NEJMra044151
Reference
PMID:11276000
  Authors
Saldanha G.
  Title
The Hedgehog signalling pathway and cancer.
  Journal
J Pathol 193:427-32 (2001)
DOI:10.1002/1096-9896(2000)9999:9999<::AID-PATH815>3.0.CO;2-N
Reference
PMID:15270885
  Authors
Saldanha G, Ghura V, Potter L, Fletcher A.
  Title
Nuclear beta-catenin in basal cell carcinoma correlates with increased proliferation.
  Journal
Br J Dermatol 151:157-64 (2004)
DOI:10.1111/j.1365-2133.2004.06048.x
Reference
PMID:14737121
  Authors
Pasca di Magliano M, Hebrok M.
  Title
Hedgehog signalling in cancer formation and maintenance.
  Journal
Nat Rev Cancer 3:903-11 (2003)
DOI:10.1038/nrc1229
Reference
PMID:15656799
  Authors
Reifenberger J, Wolter M, Knobbe CB, Kohler B, Schonicke A, Scharwachter C, Kumar K, Blaschke B, Ruzicka T, Reifenberger G.
  Title
Somatic mutations in the PTCH, SMOH, SUFUH and TP53 genes in sporadic basal cell carcinomas.
  Journal
Br J Dermatol 152:43-51 (2005)
DOI:10.1111/j.1365-2133.2005.06353.x
Reference
PMID:14556242
  Authors
Cohen MM Jr.
  Title
The hedgehog signaling network.
  Journal
Am J Med Genet A 123:5-28 (2003)
DOI:10.1002/ajmg.a.20495
Reference
PMID:11736900
  Authors
Yamazaki F, Aragane Y, Kawada A, Tezuka T.
  Title
Immunohistochemical detection for nuclear beta-catenin in sporadic basal cell carcinoma.
  Journal
Br J Dermatol 145:771-7 (2001)
DOI:10.1046/j.1365-2133.2001.04468.x
Reference
PMID:16054233
  Authors
Erb P, Ji J, Wernli M, Kump E, Glaser A, Buchner SA.
  Title
Role of apoptosis in basal cell and squamous cell carcinoma formation.
  Journal
Immunol Lett 100:68-72 (2005)
DOI:10.1016/j.imlet.2005.06.008
Reference
PMID:11130178
  Authors
Toftgard R.
  Title
Hedgehog signalling in cancer.
  Journal
Cell Mol Life Sci 57:1720-31 (2000)
DOI:10.1007/PL00000654
Reference
PMID:16822996
  Authors
Miller AJ, Mihm MC Jr.
  Title
Melanoma.
  Journal
N Engl J Med 355:51-65 (2006)
DOI:10.1056/NEJMra052166
Reference
PMID:12894244
  Authors
Chin L.
  Title
The genetics of malignant melanoma: lessons from mouse and man.
  Journal
Nat Rev Cancer 3:559-70 (2003)
DOI:10.1038/nrc1145
Reference
PMID:16750612
  Authors
Takata M, Saida T.
  Title
Genetic alterations in melanocytic tumors.
  Journal
J Dermatol Sci 43:1-10 (2006)
DOI:10.1016/j.jdermsci.2006.05.002
Reference
PMID:15841168
  Authors
Chudnovsky Y, Khavari PA, Adams AE.
  Title
Melanoma genetics and the development of rational therapeutics.
  Journal
J Clin Invest 115:813-24 (2005)
DOI:10.1172/JCI24808
Reference
PMID:16001050
  Authors
Merlino G.
  Title
Cancer biology: the weakest link?
  Journal
Nature 436:33-5 (2005)
DOI:10.1038/436033a
Reference
PMID:16001072
  Authors
Garraway LA, Widlund HR, Rubin MA, Getz G, Berger AJ, Ramaswamy S, Beroukhim R, Milner DA, Granter SR, Du J, Lee C, Wagner SN, Li C, Golub TR, Rimm DL, Meyerson ML, Fisher DE, Sellers WR.
  Title
Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma.
  Journal
Nature 436:117-22 (2005)
DOI:10.1038/nature03664
Reference
PMID:16899407
  Authors
Levy C, Khaled M, Fisher DE.
  Title
MITF: master regulator of melanocyte development and melanoma oncogene.
  Journal
Trends Mol Med 12:406-14 (2006)
DOI:10.1016/j.molmed.2006.07.008
Reference
PMID:15009714
  Authors
Tsao H, Goel V, Wu H, Yang G, Haluska FG.
  Title
Genetic interaction between NRAS and BRAF mutations and PTEN/MMAC1 inactivation in melanoma.
  Journal
J Invest Dermatol 122:337-41 (2004)
DOI:10.1046/j.0022-202X.2004.22243.x
Reference
PMID:11224709
  Authors
Gruss C, Herlyn M.
  Title
Role of cadherins and matrixins in melanoma.
  Journal
Curr Opin Oncol 13:117-23 (2001)
DOI:10.1097/00001622-200103000-00006
Reference
PMID:15721476
  Authors
Thompson JF, Scolyer RA, Kefford RF.
  Title
Cutaneous melanoma.
  Journal
Lancet 365:687-701 (2005)
DOI:10.1016/S0140-6736(05)17951-3
Reference
PMID:14695152
  Authors
Omholt K, Platz A, Kanter L, Ringborg U, Hansson J.
  Title
NRAS and BRAF mutations arise early during melanoma pathogenesis and are preserved throughout tumor progression.
  Journal
Clin Cancer Res 9:6483-8 (2003)
Reference
PMID:15557758
  Authors
Hussein MR.
  Title
The TP53 tumor suppressor gene and melanoma tumorigenesis: is there a relationship?
  Journal
Tumour Biol 25:200-7 (2004)
DOI:10.1159/000081103
Reference
PMID:10843728
  Authors
Lazar-Molnar E, Hegyesi H, Toth S, Falus A.
  Title
Autocrine and paracrine regulation by cytokines and growth factors in melanoma.
  Journal
Cytokine 12:547-54 (2000)
DOI:10.1006/cyto.1999.0614
Reference
PMID:16339096
  Authors
Cohen HT, McGovern FJ.
  Title
Renal-cell carcinoma.
  Journal
N Engl J Med 353:2477-90 (2005)
DOI:10.1056/NEJMra043172
Reference
PMID:15122209
  Authors
Pavlovich CP, Schmidt LS.
  Title
Searching for the hereditary causes of renal-cell carcinoma.
  Journal
Nat Rev Cancer 4:381-93 (2004)
DOI:10.1038/nrc1364
Reference
PMID:14634372
  Authors
Linehan WM, Walther MM, Zbar B.
  Title
The genetic basis of cancer of the kidney.
  Journal
J Urol 170:2163-72 (2003)
DOI:10.1097/01.ju.0000096060.92397.ed
Reference
PMID:14685170
  Authors
Birchmeier C, Birchmeier W, Gherardi E, Vande Woude GF.
  Title
Met, metastasis, motility and more.
  Journal
Nat Rev Mol Cell Biol 4:915-25 (2003)
DOI:10.1038/nrm1261
Reference
PMID:15611513
  Authors
Kim WY, Kaelin WG.
  Title
Role of VHL gene mutation in human cancer.
  Journal
J Clin Oncol 22:4991-5004 (2004)
DOI:10.1200/JCO.2004.05.061
Reference
PMID:17211469
  Authors
Sudarshan S, Linehan WM, Neckers L.
  Title
HIF and fumarate hydratase in renal cancer.
  Journal
Br J Cancer 96:403-7 (2007)
DOI:10.1038/sj.bjc.6603547
Reference
PMID:17287871
  Authors
Sudarshan S, Pinto PA, Neckers L, Linehan WM.
  Title
Mechanisms of disease: hereditary leiomyomatosis and renal cell cancer--a distinct form of hereditary kidney cancer.
  Journal
Nat Clin Pract Urol 4:104-10 (2007)
DOI:10.1038/ncpuro0711
Reference
PMID:12351585
  Authors
Bodmer D, van den Hurk W, van Groningen JJ, Eleveld MJ, Martens GJ, Weterman MA, van Kessel AG.
  Title
Understanding familial and non-familial renal cell cancer.
  Journal
Hum Mol Genet 11:2489-98 (2002)
DOI:10.1093/hmg/11.20.2489
Reference
PMID:17158541
  Authors
Mitra AP, Datar RH, Cote RJ.
  Title
Molecular pathways in invasive bladder cancer: new insights into mechanisms, progression, and target identification.
  Journal
J Clin Oncol 24:5552-64 (2006)
DOI:10.1200/JCO.2006.08.2073
Reference
PMID:16474624
  Authors
Wolff EM, Liang G, Jones PA.
  Title
Mechanisms of Disease: genetic and epigenetic alterations that drive bladder cancer.
  Journal
Nat Clin Pract Urol 2:502-10 (2005)
DOI:10.1038/ncpuro0318
Reference
PMID:16110317
  Authors
Wu XR.
  Title
Urothelial tumorigenesis: a tale of divergent pathways.
  Journal
Nat Rev Cancer 5:713-25 (2005)
DOI:10.1038/nrc1697
Reference
PMID:11103787
  Authors
Brown NS, Jones A, Fujiyama C, Harris AL, Bicknell R.
  Title
Thymidine phosphorylase induces carcinoma cell oxidative stress and promotes secretion of angiogenic factors.
  Journal
Cancer Res 60:6298-302 (2000)
Reference
PMID:12850530
  Authors
Bellmunt J, Hussain M, Dinney CP.
  Title
Novel approaches with targeted therapies in bladder cancer. Therapy of bladder cancer by blockade of the epidermal growth factor receptor family.
  Journal
Crit Rev Oncol Hematol 46 Suppl:S85-104 (2003)
DOI:10.1016/S1040-8428(03)00067-2
Reference
PMID:17149381
  Authors
Sugano K, Kakizoe T.
  Title
Genetic alterations in bladder cancer and their clinical applications in molecular tumor staging.
  Journal
Nat Clin Pract Urol 3:642-52 (2006)
DOI:10.1038/ncpuro0649
Reference
PMID:15746962
  Authors
Dunn KL, Espino PS, Drobic B, He S, Davie JR.
  Title
The Ras-MAPK signal transduction pathway, cancer and chromatin remodeling.
  Journal
Biochem Cell Biol 83:1-14 (2005)
DOI:10.1139/o04-121
Reference
PMID:15551095
  Authors
Williams SG, Stein JP.
  Title
Molecular pathways in bladder cancer.
  Journal
Urol Res 32:373-85 (2004)
DOI:10.1007/s00240-003-0345-y
Reference
PMID:12878745
  Authors
Nelson WG, De Marzo AM, Isaacs WB.
  Title
Prostate cancer.
  Journal
N Engl J Med 349:366-81 (2003)
DOI:10.1056/NEJMra021562
Reference
PMID:15724144
  Authors
Li L, Ittmann MM, Ayala G, Tsai MJ, Amato RJ, Wheeler TM, Miles BJ, Kadmon D, Thompson TC.
  Title
The emerging role of the PI3-K-Akt pathway in prostate cancer progression.
  Journal
Prostate Cancer Prostatic Dis 8:108-18 (2005)
DOI:10.1038/sj.pcan.4500776
Reference
PMID:16551847
  Authors
Pienta KJ, Bradley D.
  Title
Mechanisms underlying the development of androgen-independent prostate cancer.
  Journal
Clin Cancer Res 12:1665-71 (2006)
DOI:10.1158/1078-0432.CCR-06-0067
Reference
PMID:11900250
  Authors
Feldman BJ, Feldman D.
  Title
The development of androgen-independent prostate cancer.
  Journal
Nat Rev Cancer 1:34-45 (2001)
DOI:10.1038/35094009
Reference
PMID:15082523
  Authors
Heinlein CA, Chang C.
  Title
Androgen receptor in prostate cancer.
  Journal
Endocr Rev 25:276-308 (2004)
DOI:10.1210/er.2002-0032
Reference
PMID:9422516
  Authors
Koivisto P, Kolmer M, Visakorpi T, Kallioniemi OP.
  Title
Androgen receptor gene and hormonal therapy failure of prostate cancer.
  Journal
Am J Pathol 152:1-9 (1998)
Reference
PMID:10835690
  Authors
Zhao XY, Malloy PJ, Krishnan AV, Swami S, Navone NM, Peehl DM, Feldman D.
  Title
Glucocorticoids can promote androgen-independent growth of prostate cancer cells through a mutated androgen receptor.
  Journal
Nat Med 6:703-6 (2000)
DOI:10.1038/76287
Reference
PMID:10453277
  Authors
Macri E, Loda M.
  Title
Role of p27 in prostate carcinogenesis.
  Journal
Cancer Metastasis Rev 17:337-44 (1998)
DOI:10.1023/A:1006133620914
Reference
PMID:11750244
  Authors
Steers WD.
  Title
5alpha-reductase activity in the prostate.
  Journal
Urology 58:17-24; discussion 24 (2001)
DOI:10.1016/S0090-4295(01)01299-7
Reference
PMID:8069858
  Authors
Lin D, Meyer DJ, Ketterer B, Lang NP, Kadlubar FF.
  Title
Effects of human and rat glutathione S-transferases on the covalent DNA binding of the N-acetoxy derivatives of heterocyclic amine carcinogens in vitro: a possible mechanism of organ specificity in their carcinogenesis.
  Journal
Cancer Res 54:4920-6 (1994)
Reference
PMID:11527574
  Authors
Grimes CA, Jope RS.
  Title
The multifaceted roles of glycogen synthase kinase 3beta in cellular signaling.
  Journal
Prog Neurobiol 65:391-426 (2001)
DOI:10.1016/S0301-0082(01)00011-9
Reference
PMID:15947972
  Authors
Ryan AJ, Susil B, Jobling TW, Oehler MK.
  Title
Endometrial cancer.
  Journal
Cell Tissue Res 322:53-61 (2005)
DOI:10.1007/s00441-005-1109-5
Reference
PMID:14747944
  Authors
Lax SF.
  Title
Molecular genetic pathways in various types of endometrial carcinoma: from a phenotypical to a molecular-based classification.
  Journal
Virchows Arch 444:213-23 (2004)
DOI:10.1007/s00428-003-0947-3
Reference
PMID:16508724
  Authors
Shiozawa T, Konishi I.
  Title
Early endometrial carcinoma: clinicopathology, hormonal aspects, molecular genetics, diagnosis, and treatment.
  Journal
Int J Clin Oncol 11:13-21 (2006)
DOI:10.1007/s10147-005-0546-1
Reference
PMID:17028294
  Authors
Hecht JL, Mutter GL.
  Title
Molecular and pathologic aspects of endometrial carcinogenesis.
  Journal
J Clin Oncol 24:4783-91 (2006)
DOI:10.1200/JCO.2006.06.7173
Reference
PMID:11431710
  Authors
Matias-Guiu X, Catasus L, Bussaglia E, Lagarda H, Garcia A, Pons C, Munoz J, Arguelles R, Machin P, Prat J.
  Title
Molecular pathology of endometrial hyperplasia and carcinoma.
  Journal
Hum Pathol 32:569-77 (2001)
DOI:10.1053/hupa.2001.25929
Reference
PMID:15284264
  Authors
Slomovitz BM, Broaddus RR, Burke TW, Sneige N, Soliman PT, Wu W, Sun CC, Munsell MF, Gershenson DM, Lu KH.
  Title
Her-2/neu overexpression and amplification in uterine papillary serous carcinoma.
  Journal
J Clin Oncol 22:3126-32 (2004)
DOI:10.1200/JCO.2004.11.154
Reference
PMID:7585656
  Authors
Saffari B, Jones LA, el-Naggar A, Felix JC, George J, Press MF.
  Title
Amplification and overexpression of HER-2/neu (c-erbB2) in endometrial cancers: correlation with overall survival.
  Journal
Cancer Res 55:5693-8 (1995)
Reference
PMID:16248975
  Authors
Kim D, Chung J.
  Title
Akt: versatile mediator of cell survival and beyond.
  Journal
J Biochem Mol Biol 35:106-15 (2002)
DOI:10.5483/bmbrep.2002.35.1.106
Reference
PMID:12711111
  Authors
Sanchez-Cespedes M.
  Title
Dissecting the genetic alterations involved in lung carcinogenesis.
  Journal
Lung Cancer 40:111-21 (2003)
DOI:10.1016/S0169-5002(03)00033-3
Reference
PMID:11720739
  Authors
Kaye FJ.
  Title
Molecular biology of lung cancer.
  Journal
Lung Cancer 34 Suppl 2:S35-41 (2001)
DOI:10.1016/S0169-5002(01)00342-7
Reference
PMID:12616528
  Authors
Shivapurkar N, Reddy J, Chaudhary PM, Gazdar AF.
  Title
Apoptosis and lung cancer: a review.
  Journal
J Cell Biochem 88:885-98 (2003)
DOI:10.1002/jcb.10440
Reference
PMID:11807782
  Authors
Sartorius UA, Krammer PH.
  Title
Upregulation of Bcl-2 is involved in the mediation of chemotherapy resistance in human small cell lung cancer cell lines.
  Journal
Int J Cancer 97:584-92 (2002)
DOI:10.1002/ijc.10096
Reference
PMID:16064138
  Authors
Adhikary S, Eilers M.
  Title
Transcriptional regulation and transformation by Myc proteins.
  Journal
Nat Rev Mol Cell Biol 6:635-45 (2005)
DOI:10.1038/nrm1703
Reference
PMID:11463388
  Authors
Spruck C, Strohmaier H, Watson M, Smith AP, Ryan A, Krek TW, Reed SI.
  Title
A CDK-independent function of mammalian Cks1: targeting of SCF(Skp2) to the CDK inhibitor p27Kip1.
  Journal
Mol Cell 7:639-50 (2001)
DOI:10.1016/S1097-2765(01)00210-6
Reference
PMID:15109562
  Authors
Buttery RC, Rintoul RC, Sethi T.
  Title
Small cell lung cancer: the importance of the extracellular matrix.
  Journal
Int J Biochem Cell Biol 36:1154-60 (2004)
DOI:10.1016/S1357-2725(03)00261-9
Reference
PMID:11559746
  Authors
Yamada KM, Araki M.
  Title
Tumor suppressor PTEN: modulator of cell signaling, growth, migration and apoptosis.
  Journal
J Cell Sci 114:2375-82 (2001)
Reference
PMID:11905738
  Authors
Rintoul RC, Sethi T.
  Title
The role of extracellular matrix in small-cell lung cancer.
  Journal
Lancet Oncol 2:437-42 (2001)
DOI:10.1016/S1470-2045(00)00421-6
Reference
PMID:12243753
  Authors
Ekedahl J, Joseph B, Grigoriev MY, Muller M, Magnusson C, Lewensohn R, Zhivotovsky B.
  Title
Expression of inhibitor of apoptosis proteins in small- and non-small-cell lung carcinoma cells.
  Journal
Exp Cell Res 279:277-90 (2002)
DOI:10.1006/excr.2002.5608
Reference
PMID:12379883
  Authors
Osada H, Takahashi T.
  Title
Genetic alterations of multiple tumor suppressors and oncogenes in the carcinogenesis and progression of lung cancer.
  Journal
Oncogene 21:7421-34 (2002)
DOI:10.1038/sj.onc.1205802
Reference
PMID:12741677
  Authors
Yokota J, Nishioka M, Tani M, Kohno T.
  Title
Genetic alterations responsible for metastatic phenotypes of lung cancer cells.
  Journal
Clin Exp Metastasis 20:189-93 (2003)
DOI:10.1023/a:1022978932215
Reference
PMID:16870043
  Authors
Aviel-Ronen S, Blackhall FH, Shepherd FA, Tsao MS.
  Title
K-ras mutations in non-small-cell lung carcinoma: a review.
  Journal
Clin Lung Cancer 8:30-8 (2006)
DOI:10.3816/CLC.2006.n.030
Reference
PMID:15948711
  Authors
Pfeifer GP, Dammann R.
  Title
Methylation of the tumor suppressor gene RASSF1A in human tumors.
  Journal
Biochemistry (Mosc) 70:576-83 (2005)
DOI:10.1007/s10541-005-0151-y
Reference
PMID:11902573
  Authors
Altucci L, Gronemeyer H.
  Title
The promise of retinoids to fight against cancer.
  Journal
Nat Rev Cancer 1:181-93 (2001)
DOI:10.1038/35106036
Reference
PMID:10944551
  Authors
Virmani AK, Rathi A, Zochbauer-Muller S, Sacchi N, Fukuyama Y, Bryant D, Maitra A, Heda S, Fong KM, Thunnissen F, Minna JD, Gazdar AF.
  Title
Promoter methylation and silencing of the retinoic acid receptor-beta gene in lung carcinomas.
  Journal
J Natl Cancer Inst 92:1303-7 (2000)
DOI:10.1093/jnci/92.16.1303
Reference
PMID:12867060
  Authors
Hirsch FR, Scagliotti GV, Langer CJ, Varella-Garcia M, Franklin WA.
  Title
Epidermal growth factor family of receptors in preneoplasia and lung cancer: perspectives for targeted therapies.
  Journal
Lung Cancer 41 Suppl 1:S29-42 (2003)
DOI:10.1016/S0169-5002(03)00137-5
Reference
PMID:16112428
  Authors
Panani AD, Roussos C.
  Title
Cytogenetic and molecular aspects of lung cancer.
  Journal
Cancer Lett 239:1-9 (2006)
DOI:10.1016/j.canlet.2005.06.030
Reference
PMID:12407699
  Authors
Mitsuuchi Y, Testa JR.
  Title
Cytogenetics and molecular genetics of lung cancer.
  Journal
Am J Med Genet 115:183-8 (2002)
DOI:10.1002/ajmg.10692
Reference
PMID:15942304
  Authors
Breuer RH, Postmus PE, Smit EF.
  Title
Molecular pathology of non-small-cell lung cancer.
  Journal
Respiration 72:313-30 (2005)
DOI:10.1159/000085376
Reference
PMID:11895903
  Authors
Piyathilake CJ, Frost AR, Manne U, Weiss H, Bell WC, Heimburger DC, Grizzle WE.
  Title
Differential expression of growth factors in squamous cell carcinoma and precancerous lesions of the lung.
  Journal
Clin Cancer Res 8:734-44 (2002)
Reference
PMID:16189154
  Authors
Awaya H, Takeshima Y, Furonaka O, Kohno N, Inai K.
  Title
Gene amplification and protein expression of EGFR and HER2 by chromogenic in situ hybridisation and immunohistochemistry in atypical adenomatous hyperplasia and adenocarcinoma of the lung.
  Journal
J Clin Pathol 58:1076-80 (2005)
DOI:10.1136/jcp.2004.025585
Reference
PMID:21193867
  Authors
Lappano R, Maggiolini M
  Title
G protein-coupled receptors: novel targets for drug discovery in cancer.
  Journal
Nat Rev Drug Discov 10:47-60 (2011)
DOI:10.1038/nrd3320
Reference
PMID:24508914
  Authors
O'Hayre M, Degese MS, Gutkind JS
  Title
Novel insights into G protein and G protein-coupled receptor signaling in cancer.
  Journal
Curr Opin Cell Biol 27:126-35 (2014)
DOI:10.1016/j.ceb.2014.01.005
Reference
PMID:17251915
  Authors
Dorsam RT, Gutkind JS
  Title
G-protein-coupled receptors and cancer.
  Journal
Nat Rev Cancer 7:79-94 (2007)
DOI:10.1038/nrc2069
Related
pathway
fca03320  PPAR signaling pathway
fca04010  MAPK signaling pathway
fca04020  Calcium signaling pathway
fca04024  cAMP signaling pathway
fca04060  Cytokine-cytokine receptor interaction
fca04066  HIF-1 signaling pathway
fca04110  Cell cycle
fca04115  p53 signaling pathway
fca04150  mTOR signaling pathway
fca04151  PI3K-Akt signaling pathway
fca04210  Apoptosis
fca04310  Wnt signaling pathway
fca04330  Notch signaling pathway
fca04340  Hedgehog signaling pathway
fca04350  TGF-beta signaling pathway
fca04370  VEGF signaling pathway
fca04510  Focal adhesion
fca04512  ECM-receptor interaction
fca04520  Adherens junction
fca04630  JAK-STAT signaling pathway
fca04915  Estrogen signaling pathway
KO pathway
ko05200   
LinkDB

DBGET integrated database retrieval system